Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ADRB1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
mRNA | PHF1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
mRNA | MAP3K4 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
mRNA | OR13A1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
mRNA | FAM65A | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
mRNA | FKBP9 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
mRNA | ZFHX4 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
mRNA | DAG1 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
mRNA | CACNA2D2 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
mRNA | SAP30 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |